| Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death J Gisby, CL Clarke, N Medjeral-Thomas, TH Malik, A Papadaki, ... Elife, 2021 | 70 | 2021 |
| Association of histologic parameters with outcome in C3 glomerulopathy and idiopathic immunoglobulin-associated membranoproliferative glomerulonephritis HJ Lomax-Browne, NR Medjeral-Thomas, SJ Barbour, J Gisby, H Han, ... Clinical Journal of the American Society of Nephrology 17 (7), 994-1007, 2022 | 23 | 2022 |
| Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence JS Gisby, NB Buang, A Papadaki, CL Clarke, TH Malik, ... Nature Communications 13 (1), 7775, 2022 | 21* | 2022 |
| Plasma lectin pathway complement proteins in patients with COVID-19 and renal disease NR Medjeral-Thomas, A Troldborg, AG Hansen, J Gisby, CL Clarke, ... Frontiers in immunology 12, 671052, 2021 | 16 | 2021 |
| Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19 L Klaric, JS Gisby, A Papadaki, MD Muckian, E Macdonald-Dunlop, ... MedRxiv, 2021 | 11 | 2021 |
| Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients E Duijvelaar, J Gisby, JE Peters, HJ Bogaard, J Aman Nature communications 15 (1), 744, 2024 | 6* | 2024 |
| The widespread nature of Pack-TYPE transposons reveals their importance for plant genome evolution JS Gisby, M Catoni PLoS Genetics 18 (2), e1010078, 2022 | 3 | 2022 |
| Temporal multi-omic analysis of COVID-19 in end-stage kidney disease E Stephenson, E Macdonald-Dunlop, LM Dratva, RGH Lindeboom, ... medRxiv, 2024.06. 20.24309228, 2024 | | 2024 |
